SCHEMBL6537728

SCHEMBL6537728

Cc1cc([N+](=O)[O-])c2[nH]ccc(=O)c2c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
NPC1 O15118 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
TSHR P16473 5/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP3A4 P08684 2/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8103665 0.88 CYP1A2 (0.42) CYP1A2NPC1KMT2AMEN1RAB9A
SCHEMBL6537685 0.83 KMT2A (0.41) NPC1KMT2AMEN1RAB9AKDM4E
SCHEMBL25647610 0.79 CCR8 (0.42) KMT2ARAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6537634 0.74 GRIN2D (0.49) CYP1A2NPC1KMT2AKDM4EGRIN2D
SCHEMBL6537811 0.72 TDP1 (0.44) NPC1KMT2AMEN1RAB9AKDM4E
SCHEMBL6537669 0.72 LMNA (0.51) NPC1KMT2AMEN1RAB9AKDM4E
SCHEMBL2768608 0.69 ALDH1A1 (0.44) CYP1A2NPC1KMT2AMEN1KDM4E
SCHEMBL29764388 0.69 ALDH1A1 (0.44) CYP1A2NPC1KMT2AMEN1KDM4E
SCHEMBL20877299 0.69 BCHE (0.43) NPC1KMT2AMEN1RAB9ATSHR
SCHEMBL6368215 0.69 CASP6 (0.50) NPC1KMT2AMEN1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed